| Literature DB >> 34868545 |
Sergio Hernández-Jiménez1, Ana Cristina García-Ulloa2, María Teresa Alcántara-Garcés1, Luz Elena Urbina-Arronte1, Carolina Lara-Sánchez1, Héctor Rafael Velázquez-Jurado1.
Abstract
BACKGROUND AND AIMS: Type 2 diabetes mellitus is one of the major public health concerns. The current lifestyle and advances in technology resulted in the development of a virtual mode of professional healthcare, which is an effective alternative method of management of patients. This study aimed to assess the feasibility of implementation of a virtual comprehensive care programme during the COVID-19 pandemic, patients' acceptance and the changes in self-care behaviours, metabolic parameters and emotional factors.Entities:
Keywords: e-Health; pandemics; quality of life; type 2 diabetes; virtual assessment; virtual evaluation
Year: 2021 PMID: 34868545 PMCID: PMC8637687 DOI: 10.1177/20420188211059882
Source DB: PubMed Journal: Ther Adv Endocrinol Metab ISSN: 2042-0188 Impact factor: 3.565
Figure 1.Results pertaining to the satisfaction survey of patients who underwent the respective annual evaluations through virtual modes of healthcare.
Comparison of the demographic, anthropometric and metabolic parameters pertaining to the patients.
| Variable | Goal | 2019 (1 year) | 2020 (1 year) | |
|---|---|---|---|---|
| Sex | ||||
| Female (%) | – | 172 (56.4%) | 68 (52.3%) | 0.555 |
| Male (%) | – | 133 (43.6%) | 62 (47.7%) | |
| Age (years) | – | 56 (49–63) | 56 (50–62) | 0.580 |
| Years since diagnosis | ||||
| 0–1 | – | 0 (0%) | 19 (14.6%) | <0.001 |
| 2–3 | – | 137 (44.9%) | 55 (42.3%) | 0.346 |
| >3 | – | 168 (55.1%) | 56 (43.1%) | 0.014 |
| Glucose (mg/dl) | <130 | 112 (96–135) | 117 (103–137) | 0.170 |
| HbA1c (%) | <6.5 | 6.4 (6–7.3) | 6.5 (6–7.3) | 0.812 |
| Triglycerides (mg/dl) | <150 | 148 (108–199) | 145 (113–199) | 0.761 |
| Total cholesterol (mg/dl) | <180 | 167 (147–196) | 165 (147–192) | 0.761 |
| LDL cholesterol (mg/dl) | <100 | 101 (84–126) | 100 (81–119) | 0.974 |
| Non-HDL cholesterol (mg/dl) | <130 | 122 (102–152) | 123 (104–145) | 0.909 |
| Uric acid (mg/dl) | <6.3 | 5.5 (4.5–6.3) | 5.5 (4.7–6.3) | 0.300 |
| Calories consumed (kcal/day) | – | 1384 (1204–1591) | 1438 (1226–1652) | 0.096 |
| BMI (kg/m2) | – | 29.0 (26.4–32.4) | 29.4 (26–33) ( | 0.496 |
BMI, body mass index; HbA1c, glycated haemoglobin; HDL-c, high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein cholesterol.
n (%), median (interquartile range: 25–75).
p < 0.05 (Mann–Whitney U test).
Comparison of the results pertaining to self-care behaviour.
| Variable | 2019 (1 year) | 2020 (1 year) | |
|---|---|---|---|
| SMBG | |||
| No | 32 (10.5%) | 13 (10%) | 0.317 |
| Once a week | 118 (38.7%) | 41 (31.5%) | |
| Twice a week | 155 (50.8%) | 76 (58.5%) | |
| Foot care behavior | |||
| No | 41 (13.4%) | 18 (13.8%) | 0.910 |
| Yes | 264 (86.6%) | 112 (86.2%) | |
| Regular exercise | |||
| Days/week | 3 (0–5) | 0 (0–4) | <0.001 |
| Minute/week | 120 (0–240) | 0 (0–152) | <0.001 |
SMBG, self-monitoring blood glucose.
Median (interquartile range: 25–75) for regular exercise.
p < 0.05 (Mann–Whitney U test).
Comparison of the results of mental health evaluation of the patients.
| Variable | 2019 (1 year) | 2020 (1 year) | |
|---|---|---|---|
| Psychiatry consultations | |||
| Anxiety syndrome | 34 (11.1%) | 28 (21.5%) | 0.032 |
| Affective syndrome | 47 (15.45%) | 18 (13.8%) | 0.675 |
| Eating disorder | 24 (7.9%) | 14 (10.8%) | 0.327 |
| Psychotropic drug | 55 (18.2%) | 42 (32.8%) | 0.016 |
| HADS depression | |||
| Mild (0–6) | 231 (75.7%) | 91 (70%) | 0.036 |
| Moderate (7–10) | 61 (20%) | 25 (19.2%) | |
| Severe(11–21) | 13 (4.3%) | 14 (10.8%) | |
| HADS anxiety | |||
| Mild (0–7) | 237 (77.7%) | 90 (69.2%) | 0.138 |
| Moderate (8–10) | 40 (13.15%) | 26 (20%) | |
| Severe (11–21) | 28 (9.2%) | 14 (10.8%) | |
| PAID | |||
| Without distress (0–39) | 271 (88.9%) | 106 (81.5%) | 0.040 |
| Distress (⩾40) | 34 (11.1%) | 24 (18.5%) | |
| DES-SF | |||
| Lack of empowerment (0–74) | 58 (19%) | 34 (26.2%) | 0.095 |
| Empowerment (⩾75) | 81 (81%) | 96 (73.8%) | |
| DQoL | |||
| Good (35–75) | 182 (59.7%) | 71 (54.5%) | 0.329 |
DES-SF, Diabetes Empowerment Scale-Short Form; DQoL, Diabetes Quality of Life; HADS, Hospital Anxiety and Depression Scale; PAID, Problem Areas in Diabetes.
n (%).
p < 0.05 (chi-square test).